Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-23T22:09:54.331Z Has data issue: false hasContentIssue false
  • English
  • Français

Depression and use of antidepressants in Swedish nursing homes: a 12-month follow-up study

Published online by Cambridge University Press:  16 December 2013

Patrik Midlöv ,
Martin Andersson ,
Carl Johan Östgren  and
Sigvard Mölstad
Patrik Midlöv*
Affiliation:
Department of Clinical Sciences in Malmö, Center for Primary Health Care Research, Lund University, Malmö, Sweden
Martin Andersson
Affiliation:
Department of Clinical Sciences in Malmö, Center for Primary Health Care Research, Lund University, Malmö, Sweden
Carl Johan Östgren
Affiliation:
Department of Medical and Health Sciences, Linköping University, Linköping, Sweden
Sigvard Mölstad
Affiliation:
Department of Clinical Sciences in Malmö, Center for Primary Health Care Research, Lund University, Malmö, Sweden
*
Correspondence should be addressed to: Patrik Midlöv, Center for Primary Health Care Research, Lund University, Clinical Research Centre (CRC), Jan Waldenströms gata 35, Skåne University Hospital, 205 02 Malmö, Sweden, Phone: +4640 391363; Fax: +4640 391370. Email: [email protected].
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

The prescription of antidepressants in nursing homes has increased markedly since the introduction of SSRIs, while at the same time depressive symptoms often go unrecognized and untreated. The aim of this study was to examine whether depression among residents in nursing homes is treated adequately.

Methods:

A sample of 429 participants from 11 Swedish nursing homes was selected and was assessed with the Cornell Scale for Depression in Dementia (CSDD) and using medical records and drug prescription data. For 256 participants a follow-up assessment was performed after 12 months.

Results:

The prevalence of depression, according to medical records, was 9.1%, and the prevalence of CSDD score of ≥8 was 7.5%. Depression persisted in more than 50% of cases at the 12-month follow-up. Antidepressants were prescribed to 33% of the participants without a depression diagnosis or with a CSDD score of <8. 46.2% of all participants were prescribed antidepressants. 14% of the participants without a depression diagnosis or with a CSDD score of <8 had psychotropic polypharmacy. 15.2% of all participants had psychotropic polypharmacy, which persisted at the 12-month follow-up in three-quarters of cases.

Conclusion:

The prescription of antidepressants in frail elderly individuals is extensive and may be without clear indication. The clinical implication is that there is a need for systematic drug reviews at nursing homes, paying special attention to the subjects which are on antidepressants.

Keywords

depressionantidepressantsnursing homesSwedendementia
Type
Research Article
Information
International Psychogeriatrics , Volume 26 , Issue 4 , April 2014 , pp. 669 - 675
Copyright
Copyright © International Psychogeriatric Association 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alexopoulos, G. S., Abrams, R. C., Young, R. C. and Shamoian, C. A. (1988). Cornell Scale for Depression in Dementia. Biological Psychiatry, 23, 271–284.CrossRefGoogle ScholarPubMed
Banerjee, S. et al. (2011). Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet, 378, 403–411.Google Scholar
Barca, M. L., Engedal, K. and Selbaek, G. (2010). A reliability and validity study of the cornell scale among elderly inpatients, using various clinical criteria. Dementia and Geriatric Cognitive Disorders, 29, 438–447.Google Scholar
Bergdahl, E. et al. (2005). Depression among the oldest old: the Umea 85+ study. International Psychogeriatrics, 17, 557–575.Google Scholar
Bergh, S., Selbaek, G. and Engedal, K. (2012). Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomised, parallel group, placebo controlled trial. British Medical Journal, 344, e1566.Google Scholar
Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G. and Hippisley-Cox, J. (2011). Antidepressant use and risk of adverse outcomes in older people: population based cohort study. British Medical Journal, 343, d4551.Google Scholar
Fastbom, J. and Schmidt, I. (2004). Shortages in the treatment of depression of the elderly in nursing homes in Stockholm. Diagnosis is based on flimsy ground, follow up performed early. Lakartidningen, 101, 3683–3684, 3686–3688.Google Scholar
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.Google Scholar
Hughes, L. D., McMurdo, M. E. and Guthrie, B. (2013). Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity. Age Ageing, 42, 62–69.Google Scholar
Iden, K. R., Hjorleifsson, S. and Ruths, S. (2011). Treatment decisions on antidepressants in nursing homes: a qualitative study. Scandinavian Journal of Primary Health Care, 29, 252–256.Google Scholar
Lindstrom, K., Ekedahl, A., Carlsten, A., Martensson, J. and Molstad, S. (2007). Can selective serotonin inhibitor drugs in elderly patients in nursing homes be reduced? Scandinavian Journal of Primary Health Care, 25, 3–8.Google Scholar
Lustenberger, I., Schupbach, B., von Gunten, A. and Mosimann, U. (2011). Psychotropic medication use in Swiss nursing homes. Swiss Medical Weekly, 141, w13254.Google Scholar
Lyketsos, C. G. et al. (2003). Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Archives of General Psychiatry, 60, 737–746.Google Scholar
Mann, E., Kopke, S., Haastert, B., Pitkala, K. and Meyer, G. (2009). Psychotropic medication use among nursing home residents in Austria: a cross-sectional study. BMC Geriatrics, 9, 18.Google Scholar
Mottram, P. G., Wilson, K. and Strobl, J. J. (2006). Antidepressants for depressed elderly. Cochrane Database of Systematic Reviews, CD003491.Google Scholar
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V. and Ustun, B. (2007). Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet, 370, 851–858.Google Scholar
NICE (2009). Depression: The Treatment and Management of Depression in Adults. London: National Institute for Health and Clinical Excellence (NICE).Google Scholar
NICE (2011). Generalised Anxiety Disorder and Panic Disorder (with or Without Agoraphobia) in Adults. London: National Institute for Health and Clinical Excellence (NICE).Google Scholar
Schreiner, A. S., Hayakawa, H., Morimoto, T. and Kakuma, T. (2003). Screening for late life depression: cut-off scores for the Geriatric Depression Scale and the Cornell Scale for Depression in Dementia among Japanese subjects. International Journal of Geriatric Psychiatry, 18, 498–505.Google Scholar
Seitz, D., Purandare, N. and Conn, D. (2010). Prevalence of psychiatric disorders among older adults in long-term care homes: a systematic review. International Psychogeriatrics, 22, 1025–1039.Google Scholar
Shah, S., Schoenbachler, B., Streim, J. and Meeks, S. (2012). Antidepressant prescribing patterns in the nursing home: second-generation issues revisited. Journal of the American Medical Directors Association, 13, 406 e413–e408.Google Scholar
Snowdon, J. (2010). Depression in nursing homes. International Psychogeriatrics, 22, 1143–1148.Google Scholar
Swedish Council on Health Technology Assessment (SBU). (2012). Diagnosis and monitoring of mood disorders – a systematic review. Stockholm.Google Scholar
The National Board of Health and Welfare (2010). Indicators for evaluation of the quality of drug use by elderly. Stockholm.Google Scholar
Weitoft, G. R., Ericsson, O. and Fastbom, J. (2012). Prescription drugs: Health in Sweden: The National Public Health Report 2012. Chapter 18. Scandinavian Journal of Public Health, 40, 293–304.Google Scholar
WHO Collaborating Centre for Drug Statistics Methodology. (2013). Anatomical Therapeutic Chemical (ATC) Classification Index. Oslo: World Health Organisation.Google Scholar
Wilson, K., Mottram, P. G. and Vassilas, C. (2008). Psychotherapeutic treatments for older depressed people. Cochrane Database of Systematic Reviews, CD004853.Google Scholar